August 29, 2024 August 29, 2024Categories News StoriesHow the CompassHER2 pCR trial (EA1181) and other novel studies seek to optimize HER2+ breast cancer management
February 23, 2023 February 23, 2023Categories News StoriesA focus on the DREAMseq trial reveals data-driven clinical insights into the selection of first-line treatment options for patients with BRAF-mutated metastatic melanoma
June 7, 2017 June 7, 2017Categories Press ReleasesPress Release: NCI-MATCH cancer trial reaches 6,000-patient tumor sequencing goal 2 years early
